Advertisement
U.S. markets closed

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.1200-0.0350 (-0.84%)
At close: 04:00PM EST
4.0500 -0.07 (-1.70%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close4.1550
Open4.2200
Bid4.1200 x 1100
Ask4.5000 x 1400
Day's Range4.0300 - 4.2500
52 Week Range0.9200 - 7.8000
Volume423,744
Avg. Volume766,719
Market Cap259.006M
Beta (5Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-2.8900
Earnings DateMar 11, 2024 - Mar 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for OMER

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Omeros Corporation
    Analyst Report: Abbott LaboratoriesAbbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more